Explore BRB-seq, DRUG-seq and RNA-seq resources and knowledge
26 Jun 2025
If you’re considering using our RNA-seq service for your high-throughput screen, we want to make the...
Written by Daniela Cabuzu
Blog
Service
18 Jun 2025
Considering using an RNA-seq service? Read this first… For biotech and pharma teams under pressure t...
Written by Daniela Cabuzu
Blog
Service
11 Jun 2025
Since their development around 30 years ago, TaqMan™ gene expression assays have been a popular choi...
Written by Daniela Cabuzu
TaqMan
06 Jun 2025
Accurately measuring gene expression is fundamental to modern drug discovery and development, enabli...
Written by Daniela Cabuzu
TaqMan
28 May 2025
RNA sequencing (RNA-seq) is an indispensable tool in the drug development pipeline, enabling researc...
Written by Daniela Cabuzu
Drug Discovery
Tutorials
09 May 2025
Written by Daniela Cabuzu
BRB-seq
DRUG-seq
02 May 2025
3’ mRNA-seq technologies are gradually revolutionizing high-throughput bulk transcriptomics.
Written by Daniela Cabuzu
BRB-seq
DRUG-seq
3' mRNA-seq
24 Apr 2025
High-throughput screening and high-content screening are foundational to the early stages of drug di...
Written by Daniela Cabuzu
High-content screening
High-throughput screening
17 Apr 2025
High-content screening is a powerful quantitative image-based approach that has transformed drug dis...
Written by Daniela Cabuzu
High-content screening
15 Apr 2025
As a researcher performing large-scale drug-discovery, genetic perturbation, or toxicogenomic screen...
Written by Daniela Cabuzu
Drug Discovery
TempO-Seq
DRUG-seq
04 Apr 2025
For researchers in pharma, biotech, or academia looking to uncover the mechanisms of action, cytotox...
Written by Daniela Cabuzu
Drug Discovery
DRUG-seq
Cell Painting
JUMP-CP
02 Apr 2025
The Joint Undertaking in Morphological Profiling-Cell Painting Gallery (JUMP-CP) is a large-scale, h...
Written by Daniela Cabuzu
Drug Discovery
DRUG-seq
Cell Painting
JUMP-CP
Receive email updates on our latest products and services, news and event updates and more. No ads, no spam.